cancer cell
Feb 22 , 2016

Birmingham Spinout, Revitope Oncology, Inc. Raises $8.5 Million to Continue Development of Novel Cancer Immunotherapy Platform

Image courtesy of dream designs at University of Birmingham spinout, Revitope Oncology, Inc. has raised $8.5 million to continue development of its novel immunotherapy platform for the treatment of...

Feb 8 , 2016

Pitchfest 2016 now open for applications

Are you looking for investment funding?  Pitchfest, a pitching competition enabling West Midlands companies to pitch themselves to a wide variety of investors, has been launched by the University of Birmingham, Aston...

Jan 26 , 2016

Birmingham researchers win at Biotechnology YES Competition

Two teams of PhD students from the University of Birmingham have won the prizes for 'Best IP strategy' and 'Best Sustainable Innovation' at the finals of a national business start-up competition to find the entrepreneurial...

Jan 26 , 2016

PsiOxus Therapeutics Appoints Dr Paolo Paoletti as Chairman of the Board

Former President of GSK Oncology Adds Depth of Cancer R&D Leadership PsiOxus Therapeutics Ltd, the immuno-oncology company, has appointed Dr Paolo Paoletti, MD as Chairman of the Board. Dr Paoletti was most recently the...

PAGE 7 OF 22